CAMBRIDGE, Mass., July 21, 2017 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will host a conferencecall on Thursday, August 3, 2017, at 4:30 p.m. ET to review its second quarter 2017 financial results and provide an update on the company.
A live webcast of the conference call can
About Infinity Infinity is an innovative biopharmaceutical company dedicated to advancing novel medicines for people with cancer. Infinity is advancing IPI-549, an oral immuno-oncology development candidate that selectively inhibits PI3K-gamma. A Phase 1 study in patients with advanced solid tumors is ongoing. For more information on Infinity, please refer to Infinity's website at www.infi.com.
Contact: Jaren Irene Madden, Senior Director, Investor Relations and Corporate Communications Jaren.Madden@infi.com
View original content:http://www.prnewswire.com/news-releases/infinity-announces-the-date-of-its-second-quarter-2017-financial-results-conference-call-and-webcast-300491966.html
SOURCE Infinity Pharmaceuticals, Inc.
Subscribe to our Free Newsletters!
Angiogenesis is the process of formation of new blood vessels from pre-existing blood vessels. It ...
Aniridia is a genetic eye disorder in which the iris is partially or entirely absent. It is ...
Cachexia refers to severe muscle and fat loss, anorexia and marked weight loss due to an underlying ...View All